Table 2 Assessments of bone mineral density and bone metabolism biochemical markers in patients with fragility fracture during hospitalization
Age, years | ≥ 50 | 50–59 | 60–69 | 70–79 | ≥ 80 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group | Female | Male | P value | Female | Male | P value | Female | Male | P value | Female | Male | P value | Female | Male | P value |
Cases, n | 20,983 | 10,282 | Â N/A | 3,839 | 3,495 | Â N/A | 5,977 | 2,644 | Â N/A | 5,623 | 1,963 | Â N/A | 5,544 | 2,180 | Â N/A |
BMD, n (%) | 6,690 (31.88) | 2,286 (22.23) | < 0.0001 | 1,372 (35.74) | 716 (20.49) | < 0.0001 | 2,319 (38.80) | 698 (26.40) | < 0.0001 | 1870 (33.26) | 451 (22.98) | < 0.0001 | 1,129 (20.36) | 421 (19.31) | 0.2986 |
Ca/P, n (%) | 18,621 (88.74) | 8,899 (86.55) | < 0.0001 | 3,316 (86.38) | 2,882 (82.46) | < 0.0001 | 5,270 (88.17) | 2,312 (87.44) | 0.3383 | 5,051 (89.83) | 1,733 (88.28) | 0.0554 | 4,984 (89.90) | 1,972 (90.46) | 0.4594 |
BMBMs, n (%) | 1,113 (5.30) | 277 (2.69) | < 0.0001 | 190 (4.95) | 78 (2.23) | < 0.0001 | 397 (6.64) | 58 (2.19) | < 0.0001 | 340 (6.05) | 64 (3.26) | < 0.0001 | 186 (3.35) | 77 (3.53) | 0.6992 |